NetImpact Courts World Healthcare Leaders; Plans to Meet with Senior Decision and Policy Makers, Analysts and Academics at International Health Summit LAS VEGAS, Nov. 13 /PRNewswire-FirstCall/ -- NetImpact Holdings, Inc. (OTC Pink Sheets: NTHD) announced today that they plan to meet with senior decision and health policy makers, analysts and leading academics at the upcoming International Health Summit. Over 500 health sector leaders from 50 countries will gather for networking opportunities in Hollywood, FL December 7-10 at the 8th Annual International Health Summit. NetImpact expects to schedule interviews with influential leaders in the international healthcare market and identify ways of working together. NetImpact will host a cocktail reception on Monday evening, December 8, allowing the delegates to personally meet with Dr. Scott Optenberg, NetImpact's Executive Vice President of Medical Information Systems, and President of NetImpact's Healthcare Services Group. Dr. Optenberg will explain the integral role that NetImpact's products play when NetImpact is called upon to build/rebuild healthcare infrastructures in organizations, institutions, and countries. The reception will follow a joint address by Dr. Optenberg and Dr. Mamadou S. Traore, Director, Agency of Hospitals Assessment and Planning, Ministry of Health, Republic of Mali. Their session is titled: "IT Innovations: Enhancing Access in Remote Areas with New Medical and IT Technologies: Mali Case Study" and will specifically examine NetImpact's upcoming assessment of the healthcare infrastructure in Mali. About NetImpact Products -- NetCare7.0(TM) -- a medical information collection, management and analysis suite of software offered exclusively by NetImpact, which is expected to meet current and future healthcare needs. -- MDS 200 -- a self-contained medical laboratory the size of a small suitcase that automatically processes human fluid samples for early disease detection and treatment. -- NWT 4000 -- a device the size of a handheld radio that reduces chronic pain related to withdrawal from drugs, opiates, tobacco and alcohol. About NetImpact NetImpact Holdings, Inc. is a technology-to-market company focusing on the installation, restructuring and management of global healthcare and medical delivery systems. Through acquisitions and extensive access to international/U.S. distribution networks, NetImpact specializes in presenting technology that will assist in the improvement of productivity, applications development and technology transfer in developing countries. http://www.netimpact.com/ Safe Harbor Statement The statements in this release that are not historical facts are forward- looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. NetImpact Holdings, Inc. intends that such forward-looking statements be subject to the safe harbors created thereby. These forward-looking statements include predictions, estimates and other statements that involve a number of risks and uncertainties any, or all, of which could cause actual results to differ materially from any future performance suggested herein. While this outlook represents NetImpact Holdings, Inc.'s current judgment on the future direction of the business, such risks and uncertainties may individually, or mutually, impact the matters herein described, including but not limited to product acceptance, the economy, competition, governmental actions, results of litigation, technological and/or other factors, which are outside the control of NetImpact Holdings, Inc. as well as those risks and uncertainties detailed in the Company's Security and Exchange Commission filings. CONTACT Jerry Jennings Emerson Gerard Associates 561-881-7318 DATASOURCE: NetImpact Holdings, Inc. CONTACT: Jerry Jennings of Emerson Gerard Associates, +1-561-881-7318, or email, , for NetImpact Web site: http://www.netimpact.com/

Copyright